Session information

Symposium

[SY06] Symposium 6　Current status and future perspectives of molecular targeted therapy for biliary tract cancer
【E】

Thu. Feb 17, 2022 9:20 AM - 10:50 AM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Takuji Okusaka（Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital），Masato Ozaka（Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of JFCR）

+Add all to schedule

[SY06-1] Current Status and Prospects of FGFR Inhibitor Development in Japan

^○Makoto Ueno (Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center)

[SY06-2] Current status and future perspectives of molecular targeted therapy for biliary tract cancer

^○Chigusa Morizane (Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital)

[SY06-3] Current Status and Prospects for the Development of Immune Checkpoint Inhibitors in Japan

^○Masashi Kanai (Department of Therapeutic Oncology, Kyoto University)

[SY06-4] Current status and future perspectives of molecular targeted therapy for biliary tract cancer

^○Ghassan Abou-Alfa (Memorial Sloan Kettering Cancer Center)

▲